Oxford Cannabinoid Technologies Holdings Plc (LON:OCTP – Get Free Report) fell 4.2% during trading on Tuesday . The stock traded as low as GBX 0.12 ($0.00) and last traded at GBX 0.12 ($0.00). 11,402,242 shares were traded during trading, an increase of 22% from the average session volume of 9,326,041 shares. The stock had previously closed at GBX 0.12 ($0.00).
Oxford Cannabinoid Technologies Trading Down 4.2 %
The company has a 50 day moving average price of GBX 0.12 and a 200 day moving average price of GBX 0.25. The company has a market capitalization of £1.25 million, a P/E ratio of -53.10 and a beta of 0.82.
About Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions.
See Also
- Five stocks we like better than Oxford Cannabinoid Technologies
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 3 Leveraged ETFs to Multiply Returns
- How Can Investors Benefit From After-Hours Trading
- A Tale of Two Titans: Unveiling the Value in Baidu and JD.com
- How to Calculate Inflation Rate
- Is the AI-Capable iPhone 16 the Start of a Sales Super-Cycle?
Receive News & Ratings for Oxford Cannabinoid Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Cannabinoid Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
